Tci Wealth Advisors, Inc. Denali Therapeutics Inc. Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$20.88 - $35.19 $3,800 - $6,404	-182 Reduced 61.49%	114 $3,000
Q1 2022 Apr 29, 2022	BUY	$29.0 - $47.27 $2,320 - $3,781	80 Added 37.04%	296 $10,000
Q4 2021 Jan 24, 2022	BUY	$42.59 - $55.02 $2,512 - $3,246	59 Added 37.58%	216 $10,000
Q3 2021 Oct 29, 2021	BUY	$48.48 - $78.23 $3,878 - $6,258	80 Added 103.9%	157 $8,000
Q2 2021 Aug 02, 2021	BUY	$50.3 - $78.44 $553 - $862	11 Added 16.67%	77 $6,000
Q1 2021 Apr 29, 2021	BUY	$53.8 - $81.53 $3,550 - $5,380	66 New	66 $4,000

241

111M

80K

36.8K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $1.78B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.